April 2nd Shanghai and Shenzhen stock market limit-up analysis: JinYao Pharmaceutical hits 5 consecutive limit-ups

2026-04-13 03:55:11

Topic: April A-shares “Slow Bull Accumulation” Geopolitical Fluctuations Do Not Change Mid-term Optimism

            Hot Topics
            
            Watchlist
Data Center
Market Center
Capital Flows
Simulated Trading
        

        Client

For stock trading, see Jin Qilin analyst reports, authoritative, professional, timely, comprehensive, helping you uncover potential thematic opportunities!

The ChiNext Index fell sharply by 2.31% with reduced volume, over 4,300 stocks declined, and market turnover was less than 1.9 trillion yuan, with continued strength in the pharmaceutical sector. Tianjin Pharmaceutical 5 consecutive limit-ups, see the chart for details>>

A wealth of information, precise analysis, all on Sina Finance APP

Editor: Guo Xutong

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.